| April Phantana-angkool, MD | |
|
1135 116th Ave Ne Ste 200, Bellevue, WA 98004-4695 | |
| (425) 688-0212 | |
| (425) 688-0213 |
| Full Name | April Phantana-angkool |
|---|---|
| Gender | Female |
| Speciality | Surgical Oncology |
| Experience | 15 Years |
| Location | 1135 116th Ave Ne Ste 200, Bellevue, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114153749 | NPI | - | NPPES |
| 0349642 | Other | WA | STATE L&I |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD60545613 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Overlake Hospital Medical Center | Bellevue, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Overlake Medical Clinics Llc | 7012808827 | 350 |
News Archive
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in children-neuroblastoma. By studying the familial forms of this tumor, the researchers also conclude that ALK is a gene that predisposes to neuroblastoma.
Have you ever been taken off guard by a child's question about weight? Many parents struggle with what to say and how to say it. In fact, a WebMD/Sanford Health survey found that parents of teens find it more difficult to talk about weight with their child than talking about sex, drugs, alcohol or smoking.
The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.
Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (Fluzone®).
UnitedHealth Group today reported fourth quarter and full year 2010 financial results, including strong revenue growth from both its Health Benefits and Health Services business platforms. Full year and fourth quarter 2010 net earnings were $4.10 per share and $0.94 per share, respectively.
› Verified 8 days ago
| Entity Name | Overlake Medical Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801828421 PECOS PAC ID: 7012808827 Enrollment ID: O20040322001533 |
News Archive
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in children-neuroblastoma. By studying the familial forms of this tumor, the researchers also conclude that ALK is a gene that predisposes to neuroblastoma.
Have you ever been taken off guard by a child's question about weight? Many parents struggle with what to say and how to say it. In fact, a WebMD/Sanford Health survey found that parents of teens find it more difficult to talk about weight with their child than talking about sex, drugs, alcohol or smoking.
The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.
Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (Fluzone®).
UnitedHealth Group today reported fourth quarter and full year 2010 financial results, including strong revenue growth from both its Health Benefits and Health Services business platforms. Full year and fourth quarter 2010 net earnings were $4.10 per share and $0.94 per share, respectively.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| April Phantana-angkool, MD 1135 116th Ave Ne Ste 200, Bellevue, WA 98004-4695 Ph: (425) 688-0212 | April Phantana-angkool, MD 1135 116th Ave Ne Ste 200, Bellevue, WA 98004-4695 Ph: (425) 688-0212 |
News Archive
Olivier Delattre's team (Inserm Unit 830 "Genetics and Biology of Cancer") of the Institut Curie reveal in an article in the 16 October issue of Nature that alteration of the ALK gene is closely associated with the most frequent solid extracerebral tumor in children-neuroblastoma. By studying the familial forms of this tumor, the researchers also conclude that ALK is a gene that predisposes to neuroblastoma.
Have you ever been taken off guard by a child's question about weight? Many parents struggle with what to say and how to say it. In fact, a WebMD/Sanford Health survey found that parents of teens find it more difficult to talk about weight with their child than talking about sex, drugs, alcohol or smoking.
The American Asthma Foundation announced that a significant research discovery they funded has been licensed by a leading biotech company.
Novavax, Inc. announced today it has completed enrollment in the Phase II clinical study of its trivalent seasonal influenza (2008/2009 recommended strains) VLP vaccine candidate in healthy adults 60 years of age or older (older adults). This randomized, double-blind, active-controlled study is comparing the safety, tolerability and immunogenicity of two different doses (15 mcg and 60 mcg) of Novavax's trivalent seasonal influenza VLP vaccine to a commercially available trivalent inactivated vaccine, TIV (Fluzone®).
UnitedHealth Group today reported fourth quarter and full year 2010 financial results, including strong revenue growth from both its Health Benefits and Health Services business platforms. Full year and fourth quarter 2010 net earnings were $4.10 per share and $0.94 per share, respectively.
› Verified 8 days ago
David W Nelson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1135-116th Avenue Ne, Suite 605, Bellevue, WA 98004 Phone: 425-454-8161 Fax: 425-454-6304 | |
Eiji Minami, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1135 116th Ave Ne, Suite 550, Bellevue, WA 98004 Phone: 425-688-1916 Fax: 425-688-1901 | |
Sooyeon Kim, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1135 116th Ave Ne Ste 305, Bellevue, WA 98004 Phone: 425-453-1772 | |
Mrs. Eileen T. Consorti, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1135 116th Ave Ne Ste 200, Bellevue, WA 98004 Phone: 425-688-0212 | |
Dudley T Moorhead Ii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1135 116th Ave Ne Ste 220, Bellevue, WA 98004 Phone: 425-450-7007 Fax: 425-450-0026 | |
Dr. Mohamad Imad Haque, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 Fax: 425-502-3589 |